Synthetic biology-powered mRNA therapeutics

Strand Therapeutics

This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.

Senti Biosciences

This clinical-stage biotechnology company develops programmable cell and gene therapies using synthetic biology and gene circuits to treat patients with cancer and incurable diseases.

Cell Design Labs

This biotherapeutics company develops programmable cell therapies for cancer patients by engineering immune cells with synthetic genetic circuits to improve precision and safety.

Strand Tx

Strand Tx develops programmable messenger RNA therapeutics for patients with cancer and autoimmune diseases.

Noara Therapeutics

This company engineers stable and immunosilent ribonucleic acid therapies using machine intelligence to treat patients with chronic and complex diseases.

Kernal Bio

Kernal Bio develops selective messenger RNA therapeutics for patients with cancer and autoimmune diseases to enable precise in vivo cell programming.

Amply Discovery

This company develops a drug discovery platform using artificial intelligence and synthetic biology to create RNA medicines for cancer and infectious disease researchers.

Humane Genomics

This company develops synthetic oncolytic viral therapies to treat cancer patients by engineering viruses that selectively infect and destroy malignant cells.